<h4>Background</h4>Visfatin, adropin, and adiponectin are involved in many changes associated with obesity and metabolic disorders, and may be related to metabolic syndrome and cardiovascular disease. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.